Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.

Milella M, Falcone I, Conciatori F, Matteoni S, Sacconi A, De Luca T, Bazzichetto C, Corbo V, Simbolo M, Sperduti I, Benfante A, Del Curatolo A, Cesta Incani U, Malusa F, Eramo A, Sette G, Scarpa A, Konopleva M, Andreeff M, McCubrey JA, Blandino G, Todaro M, Stassi G, De Maria R, Cognetti F, Del Bufalo D, Ciuffreda L.

Sci Rep. 2017 Feb 21;7:43013. doi: 10.1038/srep43013.

2.

Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study.

Grasso C, Zugna D, Fiano V, Robles Rodriguez N, Maule M, Gillio-Tos A, Ciuffreda L, Lista P, Segnan N, Merletti F, Richiardi L.

PLoS One. 2016 Dec 30;11(12):e0169174. doi: 10.1371/journal.pone.0169174.

3.

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.

Lonardi S, Sobrero A, Rosati G, Di Bartolomeo M, Ronzoni M, Aprile G, Scartozzi M, Banzi M, Zampino MG, Pasini F, Marchetti P, Cantore M, Zaniboni A, Rimassa L, Ciuffreda L, Ferrari D, Barni S, Zagonel V, Maiello E, Rulli E, Labianca R; TOSCA (Three or Six Colon Adjuvant) Investigators..

Ann Oncol. 2016 Nov;27(11):2074-2081.

PMID:
27573560
4.

Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district.

Ponzetti A, Pinta F, Spadi R, Mecca C, Fanchini L, Zanini M, Ciuffreda L, Racca P.

Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000405. Review.

PMID:
26350200
5.

Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.

Pinto C, Di Fabio F, Rosati G, Lolli IR, Ruggeri EM, Ciuffreda L, Ferrari D, Lo Re G, Rosti G, Tralongo P, Ferrara R, Alabiso O, Chiara S, Ianniello GP, Frassoldati A, Bilancia D, Campanella GA, Signorelli C, Racca P, Benincasa E, Stroppolo ME, Di Costanzo F.

Cancer Med. 2016 Nov;5(11):3272-3281. doi: 10.1002/cam4.888.

6.

[Added value of SPECT/CT over planar imaging in improving sentinel node detection in breast cancer patients].

Frusciante V, Niccoli Asabella A, Castriotta G, Guerra M, Murgo R, Ciuffreda L, Lavelli V, Ferrari C, Rubini G.

Recenti Prog Med. 2016 Aug;107(8):444-9. doi: 10.1701/2332.25072. Italian.

PMID:
27571561
7.

Baldness and testicular cancer: the EPSAM case-control study.

Moirano G, Zugna D, Grasso C, Lista P, Ciuffreda L, Segnan N, Merletti F, Richiardi L.

Andrology. 2016 Mar;4(2):251-6. doi: 10.1111/andr.12148.

PMID:
26941123
8.

Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians.

Spadi R, Brusa F, Ponzetti A, Chiappino I, Birocco N, Ciuffreda L, Satolli MA.

World J Clin Oncol. 2016 Feb 10;7(1):27-43. doi: 10.5306/wjco.v7.i1.27. Review.

9.

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).

Leone F, Marino D, Cereda S, Filippi R, Belli C, Spadi R, Nasti G, Montano M, Amatu A, Aprile G, Cagnazzo C, Fasola G, Siena S, Ciuffreda L, Reni M, Aglietta M.

Cancer. 2016 Feb 15;122(4):574-81. doi: 10.1002/cncr.29778.

10.

"Natural" relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm.

Trabace L, Tucci P, Ciuffreda L, Matteo M, Fortunato F, Campolongo P, Trezza V, Cuomo V.

J Ethnopharmacol. 2015 Nov 4;174:396-402. doi: 10.1016/j.jep.2015.08.046.

PMID:
26325431
11.

Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncology.

Aurilio G, Gori S, Nolè F, Pruneri G, Coati F, Torri V, Lunardi G, Atzori F, La Verde N, Banna GL, Rossi A, Del Mastro L, Di Fabio F, Marcon I, Gebbia V, Loupakis F, Orlando L, Ciuffreda L, Amadio P, Luppi G, Redana S, Filippelli G, Gentile A, Collovà E.

Tumori. 2016 Jan-Feb;102(1):108-13. doi: 10.5301/tj.5000383.

PMID:
26166216
12.

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.

Pilotto S, Novello S, Peretti U, Kinspergher S, Ciuffreda L, Milella M, Carbognin L, Vavalà T, Ferrara R, Caccese M, Tortora G, Bria E.

Expert Opin Investig Drugs. 2015;24(9):1143-61. doi: 10.1517/13543784.2015.1056341. Review.

PMID:
26065529
13.

PTEN: Multiple Functions in Human Malignant Tumors.

Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S, Cognetti F, Ciuffreda L.

Front Oncol. 2015 Feb 16;5:24. doi: 10.3389/fonc.2015.00024. Review.

14.

Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.

Roila F, Ruggeri B, Ballatori E, Fatigoni S, Caserta C, Licitra L, Mirabile A, Ionta MT, Massidda B, Cavanna L, Palladino MA, Tocci A, Fava S, Colantonio I, Angelelli L, Ciuffreda L, Fasola G, Zerilli F; Italian Group for Antiemetic Research..

Ann Oncol. 2015 Jun;26(6):1248-53. doi: 10.1093/annonc/mdv132.

PMID:
25743855
15.

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

Sternberg CN, Calabrò F, Bracarda S, Cartenì G, Lo Re G, Ruggeri EM, Basso U, Gasparini G, Ciuffreda L, Ferrari V, Bonetti A, Fea E, Gasparro D, Tassinari D, Labianca R, Masini C, Fly K, Zhang K, Hariharan S, Capaccetti B, Porta C.

Oncology. 2015;88(5):273-80. doi: 10.1159/000369256.

PMID:
25592399
16.

PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.

Ciuffreda L, Falcone I, Incani UC, Del Curatolo A, Conciatori F, Matteoni S, Vari S, Vaccaro V, Cognetti F, Milella M.

Adv Biol Regul. 2014 Sep;56:66-80. doi: 10.1016/j.jbior.2014.07.002. Review.

PMID:
25088603
17.

Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).

Bennouna J, Havel L, Krzakowski M, Kollmeier J, Gervais R, Dansin E, Serke M, Favaretto A, Szczesna A, Cobo M, Ciuffreda L, Jassem J, Nicolini M, Ramlau R, Amoroso D, Melotti B, Almodovar T, Riggi M, Caux NR, Vaissière N, Tan EH.

Clin Lung Cancer. 2014 Jul;15(4):258-65. doi: 10.1016/j.cllc.2014.04.007.

PMID:
24954228
18.

Inferior vena cava prosthetic replacement in a patient with horseshoe kidney and metastatic testicular tumor: technical considerations and review of the literature.

Rispoli P, Destefanis P, Garneri P, Varetto G, Lillaz B, Castagno C, Lista P, Ciuffreda L, Fontana D.

BMC Urol. 2014 May 22;14:40. doi: 10.1186/1471-2490-14-40. Review.

19.

Role of multidimensional assessment of frailty in predicting short-term outcomes in hospitalized cancer patients: results of a prospective cohort study.

Ponzetti A, Lista P, Pagano E, Demichelis MM, Ciuffreda L, Ciccone G.

Tumori. 2014 Jan-Feb;100(1):91-6. doi: 10.1700/1430.15822.

PMID:
24675498
20.

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.

Procopio G, Derosa L, Gernone A, Morelli F, Sava T, Zustovich F, De Giorgi U, Ferrari V, Sabbatini R, Gasparro D, Felici A, Burattini L, Calvani N, Lo Re G, Banna G, Pia Brizzi M, Rizzo M, Ciuffreda L, Iacovelli R, Ferraù F, Taibi E, Bracarda S, Porta C, Galligioni E, Contu A.

Future Oncol. 2014 Aug;10(10):1741-50. doi: 10.2217/fon.14.48.

Items per page

Supplemental Content

Loading ...
Support Center